Therapy Areas: Cardiovascular
13 May 2022 - - US-based medical technology company Reflow Medical, Inc has completed patient enrollment in the DEEPER OUS clinical trial (NCT03807531) for the company's Temporary Spur Stent Syst...
9 May 2022 - - High-level results from the DELIVER Phase III trial showed British-Swedish multinational pharmaceutical and biotechnology AstraZeneca's (NASDAQ: AZN) Farxiga (dapagliflozin) reache...
4 May 2022 - - Swiss Innovation Agency Innosuisse is supporting two research collaboration projects between Swiss precision medicines developer Haya Therapeutics, SA and the University of Bern, Univer...
29 April 2022 - - The US Food and Drug Administration approved Camzyos (mavacamten, 2.5 mg, 5 mg, 10 mg, 15 mg capsules) for the treatment of adults with symptomatic New York Heart Associati...
28 April 2022 - - Israel-based medical imaging technology company Nano-X Imaging Ltd's (NASDAQ: NNOX) Nanox.AI subsidiary has received FDA 510(k) clearance for HealthOST device, an AI software th...
Related Headlines